HomeInsights52 Week High Stocks

Epigral Ltd 52 Week High

Epigral Ltd 52 Week High

stocks purchased

₹ 0.7 Cr

Volume Transacted

(Dec 11, 2024)

stocks purchased

3.4 K

Stocks Traded

(Dec 11, 2024)

Last Updated on: Dec 11, 2024

Image

Epigral Ltd

NSE: EPIGRAL

YEARHIGH

₹ 2408.35

Last updated on: Dec 11, 2024

Key Highlights

  • The 52 Week HIGH of Epigral Ltd is ₹ 2408 as of 11 Dec 24 .

Company Fundamentals for Epigral Ltd

No data available

Market Price of Epigral Ltd

1M

1Y

3Y

5Y

Monitoring Epigral Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
11 Dec 20242155.3
10 Dec 20242153
09 Dec 20242118.95
06 Dec 20242090.2
05 Dec 20242126.35
04 Dec 20242126.5
03 Dec 20242095.9
02 Dec 20242064.3
29 Nov 20242076.55
28 Nov 20242074.5

Asset Value vs Market Value of Epigral Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Epigral Ltd

No data available

* All values are in crore

Historical Net Profit of Epigral Ltd

No data available

* All values are in crore

Epigral Ltd News Hub

News

Board of Epigral approves doubling of capacity at Dahej

The Board of Epigral at its meeting held on 09 November 2024 has approved the expansion of...

Read more

09 Nov 2024 13:31

News

Epigral to table results

Epigral will hold a meeting of the Board of Directors of the Company on 9 November 2024 Po...

Read more

30 Oct 2024 16:17

News

Epigral allots 15.19 lakh equity shares under QIP issue

Epigral has allotted 15,19,180 equity shares at an issue price of Rs 2093.13 per equity sh...

Read more

25 Oct 2024 11:57

News

Board of Epigral approves fund raising up to Rs 500 cr

The Board of Epigral at its meeting held on 14 August 2024 has approved fund raising up to...

Read more

14 Aug 2024 15:22

News

Epigral to convene board meeting

Epigral will hold a meeting of the Board of Directors of the Company on 14 August 2024. Po...

Read more

10 Aug 2024 11:11

News

Board of Epigral to consider proposal for fund raising

The Board of Epigral will meet on 14 August 2024 to consider proposal for raising of funds...

Read more

09 Aug 2024 17:18

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Epigral Ltd

What is the significance of Epigral Ltd reaching its 52-week high?

Epigral Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Epigral Ltd 52-week high?

Investors monitor Epigral Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Epigral Ltd a good buy when it hits its 52-week high?

Whether Epigral Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Epigral Ltd fundamentals.

What should I consider before investing in Epigral Ltd at its 52-week high?

Before investing in Epigral Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Epigral Ltd stock price continue to rise after reaching its 52-week high?

Epigral Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions